Literature DB >> 27085290

Molecular epidemiology, evolution and phylogeny of Chikungunya virus: An updating review.

Alessandra Lo Presti1, Eleonora Cella2, Silvia Angeletti3, Massimo Ciccozzi4.   

Abstract

Chikungunya virus (CHIKV) is a mosquito-transmitted alphavirus belonging to the Togaviridae family, causing a febrile illness associated with severe arthralgia and rash. In this review, we summarized a series of articles published from 2013 to 2016 concerning CHIKV epidemiology, phylogeny, vaccine and therapies, to give an update of our most recent article written in 2014 (Lo Presti et al.,2014). CHIKV infection was first reported in 1952 from Makonde plateaus and since this time caused many outbreaks worldwide, involving the Indian Ocean region, African countries, American continent and Italy. CHIKV infection is still underestimated and it is normally associated with clinical symptoms overlapping with dengue virus, recurring epidemics and mutations within the viral genome. These characteristics promote the geographical spread and the inability to control vector-mediated transmission of the virus. For these reasons, the majority of studies were aimed to describe outbreaks and to enhance knowledge on CHIKV biology, pathogenesis, infection treatment, and prevention. In this review, 16 studies on CHIKV phylogenetic and phylodinamics were considered, during the years 2013-2016. Phylogenetic and phylodinamic analysis are useful tools to investigate how the genealogy of a pathogen population is influenced by pathogen's demographic history, host immunological milieu and environmental/ecological factors. Phylogenetic tools were revealed important to reconstruct the geographic spread of CHIKV during the epidemics wave and to have information on the circulating strains of the virus, that are important for the prediction and control of the epidemics, as well as for vaccines and antiviral drugs development. In conclusion, this updating review can give a critical appraisal of the epidemiology, therapeutic and phylogenesis of CHIKV, reinforcing the need to monitor the geographic spread of virus and vectors.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chikungunya virus (CHIKV); Epidemiology; Phylogenesys; Therapy; Vaccines

Mesh:

Substances:

Year:  2016        PMID: 27085290     DOI: 10.1016/j.meegid.2016.04.006

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  16 in total

1.  The new Chikungunya virus outbreak in Italy possibly originated from a single introduction from Asia.

Authors:  Eleonora Cella; Elisabetta Riva; Marco Salemi; Silvia Spoto; Serena Vita; Marta Fogolari; Silvia Angeletti; Massimo Ciccozzi
Journal:  Pathog Glob Health       Date:  2017-11-28       Impact factor: 2.894

2.  Characterization of β-d-N4-Hydroxycytidine as a Novel Inhibitor of Chikungunya Virus.

Authors:  Maryam Ehteshami; Sijia Tao; Keivan Zandi; Hui-Mien Hsiao; Yong Jiang; Emily Hammond; Franck Amblard; Olivia O Russell; Andres Merits; Raymond F Schinazi
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

3.  Detection of chikungunya viral RNA in mosquito bodies on cationic (Q) paper based on innovations in synthetic biology.

Authors:  Lyudmyla G Glushakova; Barry W Alto; Myong Sang Kim; Andrea Bradley; Ozlem Yaren; Steven A Benner
Journal:  J Virol Methods       Date:  2017-04-27       Impact factor: 2.014

4.  Comparative analysis of the anti-chikungunya virus activity of novel bryostatin analogs confirms the existence of a PKC-independent mechanism.

Authors:  Rana Abdelnabi; Daryl Staveness; Katherine E Near; Paul A Wender; Leen Delang; Johan Neyts; Pieter Leyssen
Journal:  Biochem Pharmacol       Date:  2016-09-21       Impact factor: 5.858

5.  Exon-Enriched Libraries Reveal Large Genic Differences Between Aedes aegypti from Senegal, West Africa, and Populations Outside Africa.

Authors:  Laura B Dickson; Corey L Campbell; Punita Juneja; Francis M Jiggins; Massamba Sylla; William C Black
Journal:  G3 (Bethesda)       Date:  2017-02-09       Impact factor: 3.154

6.  Public reaction to Chikungunya outbreaks in Italy-Insights from an extensive novel data streams-based structural equation modeling analysis.

Authors:  Naim Mahroum; Mohammad Adawi; Kassem Sharif; Roy Waknin; Hussein Mahagna; Bishara Bisharat; Mahmud Mahamid; Arsalan Abu-Much; Howard Amital; Nicola Luigi Bragazzi; Abdulla Watad
Journal:  PLoS One       Date:  2018-05-24       Impact factor: 3.240

7.  Following in the Footsteps of the Chikungunya Virus in Brazil: The First Autochthonous Cases in Amapá in 2014 and Its Emergence in Rio de Janeiro during 2016.

Authors:  Thiara Manuele Alves de Souza; Edcelha D'Athaide Ribeiro; Valmir Corrêa E Corrêa; Paulo Vieira Damasco; Carla Cunha Santos; Fernanda de Bruycker-Nogueira; Thaís Chouin-Carneiro; Nieli Rodrigues da Costa Faria; Priscila Conrado Guerra Nunes; Manoela Heringer; Monique da Rocha Queiroz Lima; Jéssica Badolato-Corrêa; Márcio da Costa Cipitelli; Elzinandes Leal de Azeredo; Rita Maria Ribeiro Nogueira; Flavia Barreto Dos Santos
Journal:  Viruses       Date:  2018-11-12       Impact factor: 5.048

8.  Assessment of Immunogenicity and Neutralisation Efficacy of Viral-Vectored Vaccines Against Chikungunya Virus.

Authors:  César López-Camacho; Young Chan Kim; Joshua Blight; Marcos Lazaro Moreli; Eduardo Montoya-Diaz; Juha T Huiskonen; Beate Mareike Kümmerer; Arturo Reyes-Sandoval
Journal:  Viruses       Date:  2019-04-03       Impact factor: 5.048

9.  Chikungunya Virus Fidelity Variants Exhibit Differential Attenuation and Population Diversity in Cell Culture and Adult Mice.

Authors:  Kasen K Riemersma; Cody Steiner; Anil Singapuri; Lark L Coffey
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

10.  Clinical and Laboratory Characteristics of an Acute Chikungunya Outbreak in Bangladesh in 2017.

Authors:  Md Mujibur Rahman; Sk Jakaria Been Sayed; Md Moniruzzaman; A K M Humayon Kabir; Md Uzzwal Mallik; Md Rockyb Hasan; Abu Bakar Siddique; Md Arman Hossain; Nazim Uddin; Md Mehedi Hassan; Fazle Rabbi Chowdhury
Journal:  Am J Trop Med Hyg       Date:  2019-02       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.